114 related articles for article (PubMed ID: 2226054)
1. [Androgen treatment of hematologic diseases].
Huang ZL
Zhonghua Nei Ke Za Zhi; 1990 Apr; 29(4):239-42. PubMed ID: 2226054
[No Abstract] [Full Text] [Related]
2. Hematologic effects of androgens revisited: an alternative therapy in various hematologic conditions.
Besa EC
Semin Hematol; 1994 Apr; 31(2):134-45. PubMed ID: 8066470
[No Abstract] [Full Text] [Related]
3. [Androgens in hematology].
Sanchez-Medal L
Cah Med; 1971 May; 12(7):515-22. PubMed ID: 5562270
[No Abstract] [Full Text] [Related]
4. [Androgens in hematology].
Sanchez-Medal L
Minerva Med; 1971 Jun; 62(51):2598-604. PubMed ID: 5566873
[No Abstract] [Full Text] [Related]
5. [Therapy of hematologic diseases using androgens].
Sánchez-Medal L
Munch Med Wochenschr; 1971 Jun; 113(25):960-5. PubMed ID: 5108720
[No Abstract] [Full Text] [Related]
6. Androgen therapy.
Longson D
Practitioner; 1972 Mar; 208(245):338-48. PubMed ID: 4557109
[No Abstract] [Full Text] [Related]
7. Use of androgens in hematologic disease.
Fried W
Postgrad Med; 1974 May; 55(5):155-61. PubMed ID: 4824723
[No Abstract] [Full Text] [Related]
8. [Do androgens have a therapeutic role in hematology?].
Delwiche F; Velu T
Rev Med Brux; 1985 Apr; 6(4):277-9. PubMed ID: 4039838
[No Abstract] [Full Text] [Related]
9. Androgens and erythropoiesis: past and present.
Shahani S; Braga-Basaria M; Maggio M; Basaria S
J Endocrinol Invest; 2009 Sep; 32(8):704-16. PubMed ID: 19494706
[TBL] [Abstract][Full Text] [Related]
10. [What is reliable in the therapy of hematologic diseases? I. Hemoblastosis and malignant lymphoproliferative diseases].
Havemann K; Schmidt M; Malchow H; Sodomann CP
Internist (Berl); 1970 Dec; 11(12):441-9. PubMed ID: 4993105
[No Abstract] [Full Text] [Related]
11. Physiologic mechanisms and the hematopoietic effects of the androstanes and their derivatives.
Gardner FH; Besa EC
Curr Top Hematol; 1983; 4():123-95. PubMed ID: 6352190
[No Abstract] [Full Text] [Related]
12. The role of androgens in the treatment of hematologic disorders.
Ammus SS
Adv Intern Med; 1989; 34():191-208. PubMed ID: 2644756
[No Abstract] [Full Text] [Related]
13. [Bone marrow biopsy in the diagnosis of blood diseases].
Nemenova NM; Protasova TG; Voronin VM
Arkh Patol; 1971; 33(3):3-11. PubMed ID: 5290858
[No Abstract] [Full Text] [Related]
14. Androgens in men--uses and abuses.
Bagatell CJ; Bremner WJ
N Engl J Med; 1996 Mar; 334(11):707-14. PubMed ID: 8594431
[No Abstract] [Full Text] [Related]
15. Refractory anaemia with excess of myeloblasts in the bone marrow: a clinical trial of androgens in 90 patients.
Najean Y; Pecking A
Br J Haematol; 1977 Sep; 37(1):25-33. PubMed ID: 271013
[TBL] [Abstract][Full Text] [Related]
16. Progress in the leukemias.
Galton DA; Spiers AS
Prog Hematol; 1971; 7(0):343-405. PubMed ID: 5006109
[No Abstract] [Full Text] [Related]
17. Androgens in anemia.
Roh BL; Wang RI
Wis Med J; 1974 Jul; 73(7):S81-2. PubMed ID: 4847027
[No Abstract] [Full Text] [Related]
18. [Treatment of bone marrow insufficiencies with androgens].
Najean Y
Therapeutique; 1971 Apr; 47(4):399-402. PubMed ID: 5564054
[No Abstract] [Full Text] [Related]
19. [Steroid therapy for hematologic diseases--indications and methods of administration].
Matsumoto N; Miwa S
Nihon Rinsho; 1979 Jun; 37(6):1302-7. PubMed ID: 384053
[No Abstract] [Full Text] [Related]
20. Androgen augmentation of epoetin.
Daniell HW
J Clin Oncol; 2003 Jun; 21(11):2224; author reply 2224-5. PubMed ID: 12775754
[No Abstract] [Full Text] [Related]
[Next] [New Search]
